Photobiomodulation Photomedicine and Laser Surgery, Journal Year: 2023, Volume and Issue: 41(6), P. 300 - 303
Published: May 30, 2023
Language: Английский
Ophthalmic and Physiological Optics, Journal Year: 2024, Volume and Issue: 44(3), P. 674 - 677
Published: March 1, 2024
Language: Английский
Citations
0
Published: Jan. 1, 2024
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Language: Английский
Citations
0
medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: April 19, 2024
Abstract Topic Existing evidence for the safety of repeated low-level red-light (RLRL) therapy myopia control. Clinical relevance Recent trials show RLRL is effective in prevention and control myopia. Establishing its profile necessary prior to widespread clinical implementation. Methods We conducted a systematic review (International Prospective Register Systematic Reviews, CRD42024516676) articles across seven databases from inception through February 10, 2024, with keywords related therapy. Pooled outcomes risk-to-benefit ratios were reported, incidence side effects was compared other anti-myopia interventions. Quality appraisal performed using Cochrane Risk Bias Tool. Results Among 689 screened articles, 20 studies (2.90%; eleven randomized controlled trials, four non-randomized one post-trial study, single-arm retrospective study two case reports identical patient.; median duration 9 months, longest 24 months) analysed, encompassing 2,380 participants aged 3-18 years 1,436 individuals undergoing Two described an patient reversible decline visual acuity optical coherence tomography (OCT) abnormalities, completely resolved 4 months after treatment cessation. No cases permanent vision loss reported. Temporary afterimage most common ocular symptom following treatment, resolving within 6 minutes reported studies. The number needed harm outweighed treat by ratio 12.7-21.4 person −3D −8D treated Incidence 0.088 per 100 patient-years (95% confidence interval [CI], 0.02-0.50), comparable spectacles designed reduction (0.22; 95% CI, 0.09-0.51; P=0.385), significantly lower than low-dose atropine (7.32; 6.65-8.05; P<0.001), orthokeratology (20.6; 16.7-25.0; contact lens (19.3; 17.6-21.1; P<0.001). Conclusion irreversible function or structural damage identified RLRL. Fundus photography OCT before during therapy, alongside home monitoring afterimages, are identify effects. Further adequately-powered longer evaluate long-term
Language: Английский
Citations
0
International Journal of Ophthalmology, Journal Year: 2023, Volume and Issue: 16(10), P. 1718 - 1720
Published: Sept. 22, 2023
AIM: To report the myopia-controlling effect of repeated low-level red-light (RLRL) therapy in patients with Stickler syndrome (STL), an inherited collagenic disease typically presenting early onset myopia.• METHODS: Three STL children, aged 3, 7, and 11y, received RLRL throughout follow-up period 17, 6mo, respectively after exclusion fundus anomalies.Data on best-corrected visual acuity (BCVA), intraocular pressure, cycloplegic subjective refraction, ocular biometrics, scanning laser ophthalmoscope, optical coherence tomography, genetic testing, systemic history, family history were recorded.• RESULTS: At initiation therapy, spherical equivalent (SE) 6 eyes from 3 ranged -3.75 to -20.38 D, axial length (AL) 23.88 30.68 mm, BCVA 0.4 1.0 (decimal notation).Myopia progression all six slowed down therapy.AL five out shortened -0.07 -0.63 mm.No side effects observed.• CONCLUSION: cases whose myopic shift AL elongation are successfully reduced even reversed therapy.
Language: Английский
Citations
1
Photobiomodulation Photomedicine and Laser Surgery, Journal Year: 2023, Volume and Issue: 41(6), P. 300 - 303
Published: May 30, 2023
Language: Английский
Citations
0